Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
13.81 USD | 0.00% | -1.22% | -23.74% |
Financials (USD)
Sales 2024 * | 1.54M | Sales 2025 * | 6.3M | Capitalization | 833M |
---|---|---|---|---|---|
Net income 2024 * | -208M | Net income 2025 * | -246M | EV / Sales 2024 * | 293 x |
Net cash position 2024 * | 380M | Net cash position 2025 * | 393M | EV / Sales 2025 * | 69.9 x |
P/E ratio 2024 * |
-4.04
x | P/E ratio 2025 * |
-3.66
x | Employees | 158 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 93.59% |
Latest transcript on Pliant Therapeutics, Inc.
1 week | -1.22% | ||
Current month | +16.84% | ||
1 month | -2.40% | ||
3 months | -20.03% | ||
6 months | -0.14% | ||
Current year | -23.74% |
Managers | Title | Age | Since |
---|---|---|---|
Bernard Coulie
CEO | Chief Executive Officer | 58 | 16-01-31 |
- | - | ||
Keith Cummings
DFI | Director of Finance/CFO | 47 | 18-11-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
David Pyott
BRD | Director/Board Member | 70 | 21-01-11 |
Suzanne Bruhn
BRD | Director/Board Member | 60 | 16-06-30 |
Gayle Crowell
BRD | Director/Board Member | 73 | 20-01-07 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.16% | 2 M€ | -.--% | ||
0.08% | 0 M€ | 0.00% | - | |
0.07% | 0 M€ | +2.72% | - | |
0.07% | 0 M€ | 0.00% | - | |
0.05% | 7 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-10 | 13.81 | 0.00% | 487,214 |
24-05-09 | 13.81 | +2.98% | 417,228 |
24-05-08 | 13.41 | -2.76% | 222,543 |
24-05-07 | 13.79 | 0.00% | 322,966 |
24-05-06 | 13.79 | -1.36% | 306,975 |
Delayed Quote Nasdaq, May 10, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-23.74% | 833M | |
+30.38% | 684B | |
+29.22% | 568B | |
-4.36% | 361B | |
+19.30% | 329B | |
+3.73% | 284B | |
+16.85% | 240B | |
+9.18% | 208B | |
-7.85% | 200B | |
+7.68% | 166B |
- Stock Market
- Equities
- PLRX Stock